In 2020, People With Diabetes May Wish to Thank the IRS
Amidst news of several Congressional hearings on the topic earlier in 2019, and continued protests by patient advocates outside of insulin manufacturers ' headquarters, as well as persistent patient and caregiver complaints about runaway U.S. insulin prices in the U.S. media, a less-acknowledged change occurred which could impact what many patients with diabetes pay next year for insulin and testing supplies.It ' s not often that Americans would actually wish to THANK the Treasury Department and the Internal Revenue Service (IRS), but in 2020, perhaps many Americans with diabetes might wish to do that!On July 17, 2019, the...
Source: Scott's Web Log - September 17, 2019 Category: Endocrinology Tags: 2019 2020 drug prices insulin insulin prices IRS Source Type: blogs
In 2020, People With Diabetes May Wish to Thank the IRS
Amidst news of several Congressional hearings on the topic earlier in 2019, and continued protests by patient advocates outside of insulin manufacturers ' headquarters, as well as persistent patient and caregiver complaints about runaway U.S. insulin prices in the U.S. media, a less-acknowledged change occurred which could impact what many patients with diabetes pay next year for insulin and testing supplies.It ' s not often that Americans would actually wish to THANK the Treasury Department and the Internal Revenue Service (IRS), but in 2020, perhaps many Americans with diabetes might wish to do that!On July 17, 2019, the...
Source: Scott's Web Log - September 17, 2019 Category: Endocrinology Tags: 2019 2020 drug prices insulin insulin prices IRS Source Type: blogs
My Trial With Sanofi's Admelog, The Biosimilar Version of Humalog
A while back Iblogged about the emergence of biosimilar insulin in the U.S., more than a decade after I studied the topic and discovered some troubling reasons none existed. Since then, in spite of top officials at the U.S. Department of Health and Human Services advocating for a more robust biosimilars market in the U.S., we have seen fewer rather than more, so that ' s not working out so well for the Trump Administration ' s promise to bring drug prices way down so far. In late 2018, Merck quietly pulled the plug on its own Lantus biosimilar which was to be branded as Lusduna Nexvue (see moreHERE for details). ...
Source: Scott's Web Log - April 9, 2019 Category: Endocrinology Tags: Eli Lilly and Company follow-on insulin analogs 2019 Admelog biosimilars generics Humalog insulin prices Medicare Sanofi Source Type: blogs
My Trial With Sanofi's Admelog, The Biosimilar Version of Humalog
A while back Iblogged about the emergence of biosimilar insulin in the U.S., more than a decade after I studied the topic and discovered some troubling reasons none existed. Since then, in spite of top officials at the U.S. Department of Health and Human Services advocating for a more robust biosimilars market in the U.S., we have seen fewer rather than more, so that ' s not working out so well for the Trump Administration ' s promise to bring drug prices way down so far. In late 2018, Merck quietly pulled the plug on its own Lantus biosimilar which was to be branded as Lusduna Nexvue (see moreHERE for details). ...
Source: Scott's Web Log - April 9, 2019 Category: Endocrinology Tags: Eli Lilly and Company follow-on insulin analogs 2019 Admelog biosimilars generics Humalog insulin prices Medicare Sanofi Source Type: blogs
We Need Get Insulin Added to the National " Preventive Medication Coverage " List
For 2018 World Diabetes Day (which is on November 14 of each year, the date of discoverer Frederick Banting ' s birth), I avoided much " celebration " or even acknowledgement. Its not that I don ' t care -- indeed, I can remember my involvement of working to get Congressional recognition of the day and helping to persuade the then-UN representative with written letters to that the United States ' citizens actually supported the day ' s (and month ' s) creation way back in the early 1990 ' s. Prior to that, diabetes wasn ' t even acknowledged outside of the medical profession.That said, in many ways, I hate these honorary "...
Source: Scott's Web Log - November 19, 2018 Category: Endocrinology Tags: 2018 drug prices insulin Source Type: blogs
We Need Get Insulin Added to the National " Preventive Medication Coverage " List
For 2018 World Diabetes Day (which is on November 14 of each year, the date of discoverer Frederick Banting ' s birth), I avoided much " celebration " or even acknowledgement. Its not that I don ' t care -- indeed, I can remember my involvement of working to get Congressional recognition of the day and helping to persuade the then-UN representative with written letters to that the United States ' citizens actually supported the day ' s (and month ' s) creation way back in the early 1990 ' s. Prior to that, diabetes wasn ' t even acknowledged outside of the medical profession.That said, in many ways, I hate these honorary "...
Source: Scott's Web Log - November 19, 2018 Category: Endocrinology Tags: 2018 drug prices insulin Source Type: blogs
A Decade+ Later, Biosimilar Insulin Is Here
More than a decade ago (the article I published on my blog was originally posted on January 8, 2007 although I began research into the subject the preceding summer, see the article athttp://blog.sstrumello.com/2007/01/business-of-diabetes-real-story-behind.html for more background), I asked a number of very legitimate questions (some of which were later answered, others were not), with the most notable one being about why so many other diabetes medicines had " generics " but insulin did not (in spite of the fact that its patents had expired years ago). Unfortunately, in my research, I discovered the some of the sordi...
Source: Scott's Web Log - April 21, 2018 Category: Endocrinology Tags: insulin analogs 2018 biogenerics biosimilars Source Type: blogs
A Decade+ Later, Biosimilar Insulin Is Here
More than a decade ago (the article I published on my blog was originally posted on January 8, 2007 although I began research into the subject the preceding summer, see the article athttp://blog.sstrumello.com/2007/01/business-of-diabetes-real-story-behind.html for more background), I asked a number of very legitimate questions (some of which were later answered, others were not), with the most notable one being about why so many other diabetes medicines had " generics " but insulin did not (in spite of the fact that its patents had expired years ago). Unfortunately, in my research, I discovered the some of the sordi...
Source: Scott's Web Log - April 21, 2018 Category: Endocrinology Tags: insulin analogs 2018 biogenerics biosimilars Source Type: blogs
A (Belated) Tribute to David Mendosa
I still have some trouble coming to grips with the fact that on May 8, 2017, the Diabetes Community (D-OC) lost one of the Diabetes Online Community ' s true pioneers and I ' d say founders: David Mendosa (http://www.mendosa.com/ -- for the time being, anyway). David passed away following a diagnosis of angiosarcoma in the liver -- which is evidently a type of cancer. I think the fact that he passed away from something other than diabetes or its complications is a true testament to David ' s belief of living life to the fullest in spite of diabetes, which need not impede anyone, in spite of being dealt a pretty l...
Source: Scott's Web Log - August 17, 2017 Category: Endocrinology Tags: 2017 D-OC David Mendosa diabetes blogger diabetes industry Rick Mendosa Source Type: blogs
A (Belated) Tribute to David Mendosa
I still have some trouble coming to grips with the fact that on May 8, 2017, the Diabetes Community (D-OC) lost one of the Diabetes Online Community ' s true pioneers and I ' d say founders: David Mendosa (http://www.mendosa.com/ -- for the time being, anyway). David passed away following a diagnosis of angiosarcoma in the liver -- which is evidently a type of cancer. I think the fact that he passed away from something other than diabetes or its complications is a true testament to David ' s belief of living life to the fullest in spite of diabetes, which need not impede anyone, in spite of being dealt a pretty l...
Source: Scott's Web Log - August 17, 2017 Category: Endocrinology Tags: 2017 D-OC David Mendosa diabetes blogger diabetes industry Rick Mendosa Source Type: blogs
How Patient Advocacy Helped Persuade Medicare to Cover Dexcom
This week, there was some very good news from the Centers for Medicare& Medicaid Services (CMS) and the JDRF, notably for people with Type 1 diabetes who rely on Dexcom CGM devices. Essentially, CMS has accepted FDA labeling for the system and will no longer prohibit coverage.JDRF did a press release which can be seen athttp://www.prnewswire.com/news-releases/jdrf-encouraged-by-medicare-decision-to-take-first-step-toward-coverage-of-continuous-glucose-monitors-for-people-with-type-1-diabetes-300390684.html.Dexcom had its own release which can be seen athttp://www.businesswire.com/news/home/20170112006146/en/Center...
Source: Scott's Web Log - January 14, 2017 Category: Endocrinology Tags: 2017 Centers for Medicare & Medicaid Services CMS Dexcom FDA Source Type: blogs
How Patient Advocacy Helped Persuade Medicare to Cover Dexcom
This week, there was some very good news from the Centers for Medicare& Medicaid Services (CMS) and the JDRF, notably for people with Type 1 diabetes who rely on Dexcom CGM devices. Essentially, CMS has accepted FDA labeling for the system and will no longer prohibit coverage.JDRF did a press release which can be seen athttp://www.prnewswire.com/news-releases/jdrf-encouraged-by-medicare-decision-to-take-first-step-toward-coverage-of-continuous-glucose-monitors-for-people-with-type-1-diabetes-300390684.html.Dexcom had its own release which can be seen athttp://www.businesswire.com/news/home/20170112006146/en/Center...
Source: Scott's Web Log - January 14, 2017 Category: Endocrinology Tags: 2017 Centers for Medicare & Medicaid Services CMS Dexcom FDA Source Type: blogs
Changes in the Price of Insulin, In Graphics!
In September 2016, the media was flooded with stories about the rediculously expensive price of EpiPens, which is basically epinephrine used to treat severe allergies (such as when some people get stung by bees or encounter peanuts), as the pens cost more than $600 for a package of two. The news was that the price of EpiPens had skyrocketed, which is a generic drug with an innovative delivery device that enables even people unfamiliar with doing so to give an epinephrine injection in order to rapidly address allergic reactions. Prices for the devices had increased by 600% over the past decade. Suddenly, ever...
Source: Scott's Web Log - November 2, 2016 Category: Endocrinology Tags: 2016 California propositions drug prices insulin insulin analogs Source Type: blogs
Changes in the Price of Insulin, In Graphics!
In September 2016, the media was flooded with stories about the rediculously expensive price of EpiPens, which is basically epinephrine used to treat severe allergies (such as when some people get stung by bees or encounter peanuts), as the pens cost more than $600 for a package of two. The news was that the price of EpiPens had skyrocketed, which is a generic drug with an innovative delivery device that enables even people unfamiliar with doing so to give an epinephrine injection in order to rapidly address allergic reactions. Prices for the devices had increased by 600% over the past decade. Suddenly, ever...
Source: Scott's Web Log - November 2, 2016 Category: Endocrinology Tags: 2016 California propositions drug prices insulin insulin analogs Source Type: blogs
Changes in the Price of Insulin, In Graphics! (and Vote'Yes' on 61 in California)
In September 2016, the media was flooded with stories about the rediculously expensive price of EpiPens, which is basically epinephrine used to treat severe allergies (such as when some people get stung by bees or encounter peanuts), as the pens cost more than $600 for a package of two. The news was that the price of EpiPens, which are a generic drug with an innovative delivery device that enables even people unfamiliar with them to give injections in order to rapidly address allergic reactions, had increased by 600% over the past decade. Suddenly, everyone was remakably empathetic to the persons who need to pay ...
Source: Scott's Web Log - November 2, 2016 Category: Endocrinology Tags: 2016 California propositions drug prices insulin insulin analogs Source Type: blogs
